![]() |
市场调查报告书
商品编码
1859821
全球治疗动物训练市场:预测至2032年-按动物类型、训练类型、训练方法、应用和地区分類的分析Therapeutic Animal Training Market Forecasts to 2032 - Global Analysis By Animal Type (Dogs, Horses / Equine Therapy, Cats, Birds and Other Animals), Training Type, Training Method, Application and By Geography |
||||||
根据 Stratistics MRC 的数据,预计到 2025 年,全球治疗动物训练市场规模将达到 3.171 亿美元,到 2032 年将达到 7.507 亿美元,预测期内复合年增长率为 13.1%。
治疗动物训练是指有系统地训练和引导动物(通常是犬、马和其他家养动物)以促进人类身心健康的过程。这些经过专门训练的动物在医院、復健中心、学校和精神健康机构等治疗场所提供支援。训练不仅强调服从性和安全性,还着重在提高动物对人类情绪和行为讯号以及医疗需求的敏感度。透过与这些动物互动,患者可以减轻压力、改善运动技能、增强社交能力并提升整体情绪,这使得治疗动物训练成为现代整体护理的重要组成部分。
人们对心理健康的认识不断提高
全球对心理健康的日益关注是推动治疗动物训练市场发展的主要动力。人们对心理健康、压力管理和创伤復原的认识不断提高,推动了对动物辅助疗法的需求。各国政府、医疗机构和教育机构正将治疗动物纳入结构化治疗方案,以改善病患的治疗效果。这种日益增长的认知正在推动政策支持、资金投入和动物辅助疗法的更广泛接受,使治疗性训练成为整体心理健康护理的基石。
缺乏标准化和认证
市场缺乏标准化和认证构成重大障碍,损害了服务的可信度和一致性。由于缺乏统一的指导方针,培训品质参差不齐,削弱了客户和医疗服务提供者之间的信任。这种分散化阻碍了市场成长,疏远了潜在投资者,并限制了服务的普及。此外,监管的不确定性增加了服务提供者的营运风险,创造了一种减缓扩张和创新的环境,最终阻碍了整体市场的发展。
训练方法的进步
行为科学、神经回馈和人工智慧辅助训练工具的创新正在为治疗动物训练开启新的可能性。先进的技术使动物能够更直观地对人类的情绪讯号、医疗状况和认知需求做出反应。这些进步正在拓展治疗的范围,从自闭症支持到创伤后压力症候群(PTSD)康復,同时提高训练效率和结果的可预测性。随着研究的深入和技术的融合,市场有望受益于可扩展、个人化和经科学检验的训练模型,从而提升治疗效果。
高营运成本
治疗性动物训练市场面临高昂的营运成本,这成为限制其成长的主要因素。专业人员配备、动物照顾、设施维护以及遵守严格法规等相关费用加重了医疗机构的财务负担。中小企业难以维持运营,限制了市场扩张。因此,这些高成本减缓了治疗性动物训练的普及速度,限制了客户的取得途径,并抑制了整体市场成长前景。
新冠疫情的影响
新冠疫情对市场造成了严重衝击,导致训练中心暂时关闭,线下课程也受到限制。保持社交距离的措施阻碍了与动物的直接互动,延误了课程进度,降低了学员的参与度。此外,供应链中断也影响了训练设备和专用动物的供应。然而,市场透过线上课程和远距培训等方式迅速调整,在一定程度上缓解了损失,同时也凸显了在未来危机中采用灵活的、技术主导的培训模式的重要性。
预计在预测期内,行为训练细分市场将成为最大的细分市场。
行为训练领域预计将在预测期内占据最大的市场份额,因为它在为动物创造治疗环境中发挥着至关重要的作用。该领域专注于服从性、情绪反应能力和情境适应能力,使动物能够安全有效地与不同人群互动。从医院到学校,行为训练在所有应用场景中都至关重要,并且是高阶治疗能力的基础。其广泛的应用范围以及在确保安全性和有效性方面的关键作用是其占据领先市场份额的主要驱动力。
预计心理健康和咨询领域在预测期内将实现最高的复合年增长率。
由于心理困扰、焦虑症和创伤相关疾病的增加,预计心理健康咨商领域在预测期内将呈现最高的成长率。治疗动物越来越多地被引入咨商过程中,以促进情绪连结、减轻焦虑并支持復原。随着全球心理健康服务的扩展,尤其是在后疫情时代,对用于精神科护理、青少年咨询和创伤治疗的训练动物的需求激增。该领域的快速成长反映了它们对情绪疗癒和心理韧性的变革性影响。
由于医疗基础设施不断完善、心理健康意识日益增强以及文化上对动物辅助疗法的接受度不断提高,预计亚太地区将在预测期内占据最大的市场份额。日本、中国和印度等国家在医院、养老院和教育机构中越来越多地采用治疗动物。政府倡议、非政府组织的参与以及不断增长的城市人口进一步推动了市场扩张。该地区多元化的人口结构和不断变化的健康理念使其成为治疗动物培训计画的重要中心。
由于北美地区拥有先进的培训体系、健全的法规结构以及广泛的心理健康倡导,预计该地区在预测期内将呈现最高的复合年增长率。美国和加拿大在将治疗动物融入临床和教育环境方面处于领先地位,并得到了保险模式和研究支持方案的推动。技术创新、官民合作关係以及对情感支持动物日益增长的需求,都促进了市场的快速成长。随着心理健康服务的不断发展,北美在治疗动物训练领域始终处于领先地位。
According to Stratistics MRC, the Global Therapeutic Animal Training Market is accounted for $317.1 million in 2025 and is expected to reach $750.7 million by 2032 growing at a CAGR of 13.1% during the forecast period. Therapeutic Animal Training refers to the structured process of preparing and guiding animals, typically dogs, horses, or other domesticated species, to assist in promoting physical, emotional, and cognitive well-being in humans. These specially trained animals provide support in therapeutic settings, including hospitals, rehabilitation centers, schools, and mental health facilities. The training focuses not only on obedience and safety but also on developing an animal's sensitivity to human emotions, behavioral cues, and medical needs. Through interactions with these animals, individuals can experience reduced stress, improved mobility, enhanced social engagement, and overall emotional upliftment, making Therapeutic Animal Training a vital component of modern holistic care.
Rising Mental Health Awareness
The growing global emphasis on mental health is a key driver for the Therapeutic Animal Training market. Increased recognition of emotional well-being, stress management, and trauma recovery has accelerated demand for animal-assisted therapies. Governments, healthcare providers, and educational institutions are integrating therapeutic animals into structured programs to enhance patient outcomes. This rising awareness is fostering policy support, funding initiatives, and broader acceptance of animal-assisted interventions, positioning therapeutic training as a cornerstone of holistic mental health care.
Lack of Standardization & Certification
The lack of standardization and certification in the market acts as a significant barrier, undermining credibility and consistency across services. Without uniform guidelines, training quality varies widely, reducing trust among clients and institutions. This fragmentation hinders market growth, deterring potential investors and limiting adoption. Moreover, regulatory ambiguities increase operational risks for providers, creating an environment where scaling and innovation are slowed, ultimately stifling the market's overall development.
Advancements in Training Methodologies
Innovations in behavioral science, neurofeedback, and AI-assisted training tools are unlocking new opportunities in therapeutic animal training. Enhanced techniques enable animals to respond more intuitively to human emotional cues, medical conditions, and cognitive needs. These advancements are expanding the scope of therapy-from autism support to PTSD recovery-while improving training efficiency and outcome predictability. As research deepens and technology integrates, the market is poised to benefit from scalable, personalized, and scientifically validated training models that elevate therapeutic impact.
High Operational Costs
Therapeutic Animal Training market faces significant challenges due to high operational costs, which act as a major hindrance to growth. Expenses related to specialized staff, animal care, facility maintenance, and compliance with stringent regulations increase the financial burden on providers. Small and medium-sized enterprises struggle to sustain operations, limiting market expansion. Consequently, these elevated costs slow adoption rates, restrict accessibility for clients, and dampen overall market growth prospects.
Covid-19 Impact
The Covid-19 pandemic significantly disrupted the market, causing temporary closures of training centers and limited in-person sessions. Social distancing measures hindered hands-on animal interactions, delaying program schedules and reducing client participation. Additionally, supply chain interruptions affected access to training equipment and specialized animals. However, the market adapted through virtual sessions and teletraining approaches, partially mitigating losses while highlighting the need for flexible, technology-driven training models in future crises.
The behavioral training segment is expected to be the largest during the forecast period
The behavioral training segment is expected to account for the largest market share during the forecast period, due to its foundational role in preparing animals for therapeutic environments. This segment focuses on obedience, emotional responsiveness, and situational adaptability, ensuring animals can safely and effectively interact with diverse populations. Behavioral training is essential across all applications-from hospitals to schools-and serves as the baseline for advanced therapeutic capabilities. Its broad applicability and critical importance in ensuring safety and efficacy drive its leading market share.
The mental health & counseling segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the mental health & counseling segment is predicted to witness the highest growth rate, due to rising psychological distress, anxiety disorders, and trauma-related conditions. Therapeutic animals are increasingly integrated into counseling sessions to foster emotional connection, reduce anxiety, and support recovery. As mental health services expand globally, particularly in post-pandemic contexts, demand for trained animals in psychiatric care, youth counseling, and trauma therapy is surging. This segment's rapid growth reflects its transformative impact on emotional healing and resilience.
During the forecast period, the Asia Pacific region is expected to hold the largest market share due to expanding healthcare infrastructure, rising mental health awareness, and cultural openness to animal-assisted therapies. Countries like Japan, China, and India are witnessing increased adoption of therapeutic animals in hospitals, elder care, and educational settings. Government initiatives, NGO involvement, and growing urban populations further support market expansion. The region's diverse demographics and evolving wellness priorities position it as a key hub for therapeutic animal training programs.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to advanced training ecosystems, strong regulatory frameworks, and widespread mental health advocacy. The U.S. and Canada lead in integrating therapeutic animals into clinical and educational settings, supported by insurance models and research-backed protocols. Technological innovation, public-private partnerships, and growing demand for emotional support animals contribute to rapid market growth. As mental health services evolve, North America remains at the forefront of therapeutic animal training advancements.
Key players in the market
Some of the key players profiled in the Therapeutic Animal Training Market include Zoetis, Eco Animal Health Group, Merck Animal Health (MSD Animal Health), Hester Biosciences, Boehringer Ingelheim Animal Health, Ourofino Saude Animal, Elanco Animal Health, Ceva Sante Animale, Idexx Laboratories, Norbrook Laboratories, Virbac, Vetoquinol, Dechra Pharmaceuticals, Phibro Animal Health Corporation and Neogen Corporation.
In June 2025, Infosys has entered a strategic collaboration with Zoetis, the world's leading animal health company, to enhance Zoetis' IT operations and digital capabilities. This long-term engagement aims to integrate advanced AI solutions and automation services, providing greater agility to respond to the evolving business landscape and customer needs.
In March 2025, Elanco signed a research agreement with WEDterinary LLC, co-founded by William Doyle, to explore novel therapies for chronic kidney disease in cats and investigate approaches to extend the healthy lifespan of pets. The collaboration aims to leverage gene therapy and AI technologies to advance pet healthcare.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.